Abstract
Objective:
Clinical trials have indicated that water-soluble fiber from oats reduces serum cholesterol among hypercholesterolemic patients on a low-fat diet. We examined the effect of dietary fiber intake on serum lipids among persons without hypercholesterolemia.
Design:
Randomized controlled trial.
Setting and subjects:
We recruited 110 participants who were aged 30–65 years and had a serum cholesterol level <240 mg/dl from community.
Intervention:
Study participants were randomly assigned to receive 8 g per day of water-soluble fiber from oat bran or a control intervention.
Results:
At baseline, the mean levels of serum cholesterol and other measured variables were comparable between the high-fiber and control groups. Over the 3-month intervention, mean changes (95% confidence interval (CI)) in total, HDL-, and LDL-cholesterol were −2.42 mg/dl (−8.90 to 4.05 mg/dl; P=0.46), −0.24 mg/dl (−2.19 to 1.71 mg/dl; P=0.81), and −1.96 mg/dl (−7.32 to 3.40 mg/dl; P=0.47) in the fiber group and −0.02 mg/dl (−5.29 to 5.26 mg/dl; P=0.99), 1.42 mg/dl (−0.74 to 3.59 mg/dl; P=0.19), and −0.64 mg/dl (−5.30 to 4.03 mg/dl; P=0.79) in the control group, respectively. The net changes (95% confidence interval) in total, HDL-, and LDL-cholesterol were −2.40 mg/dl (−10.6 to 5.81 mg/dl; P=0.56), −1.66 mg/dl (−4.55 to 1.22 mg/dl; P=0.26) and −1.33 mg/dl (−8.33 to 5.68 mg/dl; P=0.71), respectively.
Conclusions:
Our study does not support the hypothesis that water-soluble fiber intake from oat bran reduces total and LDL-cholesterol in study participants with a normal serum cholesterol level.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974). Enzymatic determination of total serum cholesterol. Clin Chem 20, 470–475.
American Heart Association (2003). Heart disease stroke statistics – 2004 update. Dallas, TX: American Heart Association.
Anderson JW, Garrity TF, Wood CL, Whitis SE, Smith BM, Oeltgen PR (1992). Prospective, randomized, controlled comparison of the effects of low-fat and low-fat plus high-fiber diets on serum lipid concentrations. Am J Clin Nutr 56, 887–894.
Anderson JW, O'Neal DS, Riddell-Mason S, Floore TL, Dillon DW, Oeltgen PR (1995). Postprandial serum glucose, insulin, and lipoprotein responses to high- and low-fiber diets. Metabolism: Clin Exper 44, 848–854.
Bazzano LA, He J, Ogden LG, Vupputuri S, Loria C, Myers L et al. (2003). Dietary fiber intake and reduced risk of coronary heart disease in US men and women. Arch Intern Med 163, 1897–1904.
Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P et al. (1994). Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Euro J Clin Nut 48, 465–474.
Brown L, Rosner B, Willett WW, Sacks FM (1999). Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30–42.
Burslem J, Schonfeld G, Howald MA, Weidman SW, Miller JP (1978). Plasma apoprotein and lipoprotein lipid levels in vegetarians. Metabolism 27, 711–719.
de Groot AP, Luyken R, Pikaar NA (1963). Cholesterol-lowering effect of rolled oats. Lancet 2, 303–304.
Demark-Wahnefried W, Bowering J, Cohen PS (1990). Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets. J Am Diet Assoc 90, 223–229.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adults Treatment Panel III). JAMA 285, 2486–2497.
Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB et al. (2003). Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290, 891–897.
Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD (1998). Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 97, 946–952.
He J, Klag MJ, Wu Z, Qian MC, Chen JY, Mo PS et al. (1996). Effect of migration and related environmental changes on serum lipid levels in southwestern Chinese men. Am J Epidemiol 144, 839–848.
Jenkins DJ, Kendall CW, Vuksan V, Vidgen E, Parker T, Faulkner D et al. (2002). Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 75, 834–839.
Kris-Etherton PM, Krummel D, Russell ME, Dreon D, Mackey S, Borchers J et al. (1988). The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc 88, 1373–1400.
LaRosa JC, He J, Vupputuri S (1999). Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282, 2340–2346.
Pietinen P, Rimm EB, Korhonen P, Harman AM, Willett WC, Albanes D et al. (1996). Intake of dietary fiber and risk of coronary heart disease in a cohort of Finish men: The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation 94, 2720–2727.
Rimm EB, Ascherio A, Giovannucci E, Spiegleman D, Stampfer MJ, Willett WC (1996). Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 275, 447–451.
Ripsin CM, Keenan JM, Jacobs DR, Elmer PJ, Welch RR, Van Horn L et al. (1992). Oat products and lipid lowering: a meta-analysis. JAMA 267, 3317–3325.
Sacks FM, Castelli WP, Donner A, Kass EH (1975). Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med 292, 1148–1151.
Schakel SF, Sievart YA, Buzzard IM (1988). Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc 8, 1268–1271.
Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D et al. (2001). Atherosclerosis Risk in Communities Study Group. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104, 1108–1113.
Soeldner JS, Slone D (1966). Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes 14, 771–779.
Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD (2000). Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 284, 311–318.
Swain JF, Rouse IL, Curley CB, Sacks FM (1990). Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med 322, 147–152.
Uusitupa MI, Ruuskanen E, Makinen E, Laitinen J, Toskala E, Kervinen K et al. (1992). A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr 11, 651–659.
Van Horn L (1997). Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 95, 2701–2704.
Van Horn LV, Liu K, Parker D, Emidy L, Liao YL, Pan WH et al. (1986). Serum lipid response to oat product intake with a fat-modified diet. J Am Diet Assoc 86, 759–764.
Van Horn L, Emidy LA, Liu KA, Liao YL, Ballew C, King J et al. (1988). Serum lipid response to a fat-modified, oatmeal-enhanced diet. Prev Med 17, 377–386.
Van Horn L, Moag-Stahlberg A, Liu K, Ballew C, Ruth K, Hughes R et al. (1991). Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health 81, 183–188.
Wolk A, Manson JE, Stampfer MJ, Colditz GA, Hu FB, Speizer FE et al. (1999). Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 281, 1998–2004.
Acknowledgements
This study was supported by a grant (HL60300) from the National Heart, Lung, and Blood Institute of the National Institutes of Health and partially by Tulane-Charity-LSU General Clinical Research Center (RR05096). Drs J Chen and RP Wildman were supported by Building Interdisciplinary Research Careers in Women's Health Scholarship (K12 HD43451) from the National Heart, Lung, and Blood Institute, National Institutes of Health Bethesda, Maryland. The Quaker Oats Company provided oat bran concentrate and cold cereal for the study.
The authors would like to express their appreciation to all study participants and study staff members, including study coordinator, Sara Bienvenu, RN, Kenya Morris-Brooks, MPH, Liying Hao, MD, Timir Paul, MD, MPH, Rhonda Fontenot, RN, Patricia Early, RN, Angela Cemo, RD, and Rosanne Farris, RD.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantor: J He.
Contributors: JC and JH contributed to conception and design of the study, conduct of the study, analysis and interpretation of the data, drafting of the article, and critical revision of the article for important intellectual content. RPW contributed to analysis and interpretation of the data and critical revision of the article for important intellectual content. KR contributed to conduct of the study, and critical revision of the article for important intellectual content. RHS and PKW contributed to conception and design of the study and critical revision of the article for important intellectual content. In addition, JH contributed to Obtaining of funding.
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Chen, J., He, J., Wildman, R. et al. A randomized controlled trial of dietary fiber intake on serum lipids. Eur J Clin Nutr 60, 62–68 (2006). https://doi.org/10.1038/sj.ejcn.1602268
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602268
Keywords
This article is cited by
-
Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials
European Journal of Nutrition (2022)
-
Dose-response effect of prebiotic ingestion (β-glucans isolated from Saccharomyces cerevisiae) in diabetic rats with periodontal disease
Diabetology & Metabolic Syndrome (2021)
-
Nutritional advantages of oats and opportunities for its processing as value added foods - a review
Journal of Food Science and Technology (2015)
-
The cholesterol-lowering effects of oat varieties based on their difference in the composition of proteins and lipids
Lipids in Health and Disease (2014)
-
Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: secondary analysis of a randomized clinical trial
European Journal of Clinical Nutrition (2013)